Privia Health Group, Inc.
PRVA
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $2.6B
$20.79
▲ +0.35%
P/E
122.96
Mkt Cap
$2.6B
52-Wk Range
$19.53–$28.82
52-Week Range
$19.53 - $28.82
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 10.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Integrated multi-stakeholder platform connecting physicians, payers, and health systems
- Proprietary technology and data analytics enabling practice optimization and population health management
- Scale and network effects from serving thousands of independent physicians across the United States
- Established relationships with major health plans and health systems creating switching costs
- Dual revenue model from both providers and payers generating diversified income streams
Bear Case
2 risks
- Average volatility.
- Extreme premium - high expectations embedded
Growth
Stable outlook
Accelerating shift toward value-based care models rewarding quality and efficiency over volume
Value
Extreme premium - high expectations embedded
Momentum
Stable
+0.3% over 3m
Quality
Thin
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying PRVA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of $0.07 vs $0.07 consensus (+3.9% surprise). Revenue of $632.6M vs $597.3M expected (+5.9%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+3.9%
Revenue trend · last 8Q
—
—
+5%
+16%
+23%
+33%
+17%
+26%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$422.3M
$437.9M
$460.9M
$480.1M
$521.2M
$580.4M
$541.2M
$603.8M
Margins · last 8Q
Gross
—
Operating
—
Profit
0.5%
Wall Street consensus
4 analysts · 75% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
75%
Hold
25%
Sell
0%
Median Price Target
—
Latest: Citi · Jul 23, 2026
vs Industry
How PRVA stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related